Invesaro

Stocks TDY Financial statements

Financial statements

TELEDYNE TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TELEDYNE TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue2,1502,6042,9023,1643,0864,6145,4595,6365,6706,115
Cost of revenue1,3301,6241,7911,9201,9052,7733,1283,1963,2353,501
Gross profit8209801,1111,2431,1811,8412,3302,4392,4352,615
Research and development352356293317
Selling, general and administrative5806586947156621,068804852903931
Operating income2413224174924806249721,0349891,150
Interest expense23.635.529.22115.390.889.377.357.959.6
Other non-operating income10.7-15.5-10.7-5-7.22.53.4-12.2-4.1-21.6
Pre-tax income2412873944744705349089599381,095
Income tax50.459.860.171.467.888.511972.3117199
Net income to minority interests00000.30.91.50.9
Net income191227334402402445789886819895
EBITDA3284355306045969961,3041,3511,2991,486
EPS, basic5.526.459.3211.0810.9510.3116.8518.8017.4319.12
EPS, diluted5.376.269.0110.7310.6210.0516.5318.4917.2118.88
Shares, basic (weighted)34.635.235.836.336.743.246.847.14746.8
Shares, diluted (weighted)35.536.33737.537.944.347.747.947.647.4

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents98.670.9143200673475638648650352
Receivables384388417460402768884900901992
Inventory3144003643933477538919189141,043
Other current assets49.762.745.859.978.1118131213167293
Total current assets8461,0121,1141,3141,7232,4292,8182,9812,9453,056
Property, plant and equipment341443443488489828770777745839
Lease right-of-use assets127123145142142129156
Goodwill1,1941,7771,7352,0512,1507,9877,8738,0037,9918,688
Intangible assets1322421932674102,7422,4412,2782,0132,100
Other non-current assets70.888.984.6225245321274285280317
Total assets2,7743,8463,8094,5805,08514,43014,35414,52814,20115,285
Accounts payable139192228271229470506385416487
Accrued liabilities2613453563924341,029718781845923
Deferred revenue112127160186188241313370
Short-term debt1023.613710197.603006000.3450
Total current liabilities5025417217637611,4981,5231,7661,2621,860
Long-term debt5101,0646107506814,0993,6212,6452,6492,025
Lease liabilities119117138126123110135
Other non-current liabilities202289249352375585547476381516
Total liabilities1,2201,8991,5801,8651,8566,8086,1815,3024,6454,771
Total debt5101,0647488517794,0993,9213,2452,6492,475
Paid-in capital3363373443613904,3174,3534,4074,4154,383
Retained earnings1,9122,1402,5242,9263,3283,7734,5625,4486,2677,141
Treasury stock-243-201-145-96.4-59.5-38.8-200-292-585
Other comprehensive income-451-329-493-476-430-430-727-634-840-425
Shareholders' equity1,5541,9472,2302,7153,2297,6228,1699,2219,54910,514
Total equity1,5541,9472,2302,7153,2297,6228,1699,2219,54910,514
Total liabilities and equity2,7743,8463,8094,5805,08514,43014,35414,52814,20115,285
Shares outstanding35.135.536.136.53746.746.947.346.746.2

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income191227334402402445789887821896
Depreciation and amortization87.3113113112116372332316310336
Deferred income tax-7.9-12.3-97.4-98.1-58.6
Change in receivables-11.4-19.6-66.7-58.8
Change in inventory-9.1-7.4-1.712.254.37-155-14.3-10.4-42.8
Change in payables2.112.439.929.6-46.399.145.9-12533.735.6
Cash from operations3173754474826198254878361,1921,191
Capital expenditures-87.6-58.5-86.8-88.4-71.4-102-92.6-115-83.7-117
Acquisitions-3.1-484-29-3,723-99.6-77.7-124-821
Cash from investing-151-831-88.6-572-99.4-3,824-175-190-207-938
Debt issued026801502.73,97600
Debt repaid-185
Stock issued36.124.937.234.636.325.423.645.437.948.8
Share buybacks0000-354-403
Cash from financing-145414-271142-61.82,807-110-652-946-555
Exchange rate effect-7.514.7-15.45.115.9-5.8-3815.9-37.44.4
Net change in cash13.5-27.771.657474-19816310.21.5-297
Free cash flow2293163603945487233947211,1081,074
Interest paid23.419.111779.387.973.471.3
Income taxes paid24.636.764.711074.583.6212313213280

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $614.15 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin43.3%Gross profit / revenue.
Operating margin19.4%Operating income / revenue.
EBITDA margin24.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin18.7%Pre-tax income / revenue.
Net margin15.3%Net income / revenue.
FCF margin17.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin19.9%Cash from operations / revenue.
Effective tax rate18.4%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)8.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)6.4%Net income / average total assets.
Return on invested capital (ROIC)8.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue5.3%Research and development expense / revenue.
SG&A / revenue15.1%Selling, general and administrative expense / revenue.
Capex / revenue2.0%Capital expenditures / revenue.
D&A / revenue5.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y7.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y14.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y7.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y3.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y17.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y16.2%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y5.8%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y19.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y14.4%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y4.4%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y20.0%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y9.2%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y4.3%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y17.4%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y9.7%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y4.5%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y12.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-0.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y34.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y14.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-3.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y39.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y14.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y10.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y8.8%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y26.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y7.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y2.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y24.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y4.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.18xCurrent assets / current liabilities.
Quick ratio0.87x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.23x(Cash + short-term investments) / current liabilities.
Debt / equity0.19xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets13.3%Total debt / total assets.
Liabilities / assets28.5%Total liabilities / total assets.
Net debt$1.69BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA1.07xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage24.5xOperating income / interest expense.
Working capital$1.73BCurrent assets - current liabilities.
Goodwill and intangibles / assets69.7%(Goodwill + intangible assets) / total assets.
Tangible book value$272.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.42xRevenue / average total assets.
Fixed asset turnover7.65xRevenue / average property, plant and equipment.
Inventory turnover3.10xCost of revenue / average inventory.
Days inventory118 days365 x average inventory / cost of revenue.
Receivables turnover6.80xRevenue / average receivables.
Days sales outstanding54 days365 x average receivables / revenue.
Days payables50 days365 x average accounts payable / cost of revenue.
Cash conversion cycle122 daysDays inventory + days sales outstanding - days payables.
FCF conversion117.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow10.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$20.78Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$135.92Revenue / diluted weighted shares.
FCF per share$24.35Free cash flow / diluted weighted shares.
Operating cash flow per share$27.11Cash from operations / diluted weighted shares.
Book value per share$235.54Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$5.88Tangible book value / shares outstanding.
Cash per share$7.34(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$28.47BShare price x shares outstanding.
Enterprise value$30.16BMarket cap + total debt - cash - short-term investments.
P/E29.2xMarket cap / net income. Only when net income is positive.
P/S4.47xMarket cap / revenue.
P/B2.61xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book105xMarket cap / tangible book value, when positive.
P/FCF24.9xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF22.4xMarket cap / cash from operations, when positive.
EV/Sales4.73xEnterprise value / revenue.
EV/EBIT24.3xEnterprise value / operating income, when both are positive.
EV/EBITDA19.1xEnterprise value / EBITDA, when both are positive.
EV/FCF26.4xEnterprise value / free cash flow, when both are positive.
FCF yield4.0%Free cash flow / market cap.
Earnings yield3.4%Net income / market cap (the inverse of P/E).
PEG6.45xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was TELEDYNE TECHNOLOGIES INC's revenue in fiscal 2025?

TELEDYNE TECHNOLOGIES INC reported revenue of $6.12B for fiscal 2025, 7.9% higher than the year before.

Was TELEDYNE TECHNOLOGIES INC profitable in fiscal 2025?

Yes. Net income was $894.8M, a net margin of 14.6%.

How much free cash flow did TELEDYNE TECHNOLOGIES INC generate in fiscal 2025?

Cash from operations of $1.19B minus capital expenditures of $117.3M left free cash flow of $1.07B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TELEDYNE TECHNOLOGIES INC